Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
64.00    3.00 (4.92%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £9.29m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Update

2 Feb 2023 07:00

RNS Number : 6547O
Ingenta PLC
02 February 2023
 

2 February 2023

 

Ingenta plc ("Ingenta" or the "Group")

Trading Update

Ingenta plc (AIM: ING), a leading software and services provider to the publishing and media industries, is pleased to provide the following trading update for the year ended 31 December 2022.

The Group expects to report revenue of approximately £10.45m (2021: £10.15m) and adjusted EBITDA of approximately £1.95m (2021: £1.45m), in line with market expectations. Closing year end cash balances were £2.4m (2021: £3.0m) after completion of the previously announced £2.07m tender offer in November 2022. Ingenta has no debt.

In line with the previously stated intention to implement a progressive dividend policy, the Board intends to pay a final dividend of 2.25 pence (2021: 2 pence) per ordinary share for the 2022 financial year, subject to shareholder approval at the 2023 AGM. The proposed final dividend timetable will be announced following the 2023 AGM.

The Group expects to announce its final results for the year ended 31 December 2022 in April 2023.

Scott Winner, Chief Executive Officer, commented:

"I'm pleased to report that in 2022 the Group delivered top line revenue growth combined with strong efficiency gains delivered in prior periods. This growth was generated primarily from our Commercial product division where we have had strong uptake of our consultancy and managed service offering.

On the new business front, we added three customers to our web-based digital content distribution platform and encouragingly, have also simplified the upgrade process for customers looking to migrate to more advanced SaaS-based solutions. Sales pipeline activity is encouraging, and we are actively looking to build on the revenue growth reported in 2022."

For further information contact:

 

Ingenta Plc Scott Winner, Chief Executive Officer

Jon Sheffield, Chief Financial Officer

+44 (0) 1865 397 800

 

Cenkos Securities plcKaty Birkin

Callum Davidson

 

+44 (0) 20 7397 8900

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVFLFBXLLFBBV
Date   Source Headline
10th Dec 20197:00 amRNSGrant of Options
18th Nov 20191:53 pmRNSDirector/PDMR Shareholding
14th Nov 20195:06 pmRNSTransaction in Own Shares
28th Oct 20197:00 amRNSContract Wins
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSTransaction in Own Shares
10th Oct 20197:00 amRNSShare Buyback Programme
23rd Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSContract Wins
11th Jun 20197:00 amRNSContract Wins
23rd May 201912:45 pmRNSAGM Statement
23rd Apr 20195:23 pmRNSHolding(s) in Company
18th Apr 20192:30 pmRNSDividend Declaration, Posting of AR&A & AGM Notice
2nd Apr 20194:30 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSFinal Results
6th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSDirector/PDMR Shareholding
30th Jan 20197:00 amRNSTrading Statement
10th Dec 20187:00 amRNSContract Renewals
31st Oct 20187:00 amRNSAppointment of Director
3rd Oct 201811:00 amRNSAppointment of Director
18th Sep 20187:00 amRNSHalf-year Report
14th Aug 20187:00 amRNSIngenta announces two new multi-year contracts
9th Aug 20187:00 amRNSDirectorate Update
26th Jun 20185:58 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSIngenta announces new VAR partnership with ATC
24th May 201812:09 pmRNSAGM Statement & Results of AGM
27th Apr 20187:00 amRNSDividend Declaration, Posting of AR&A & AGM Notice
29th Mar 20187:00 amRNSFinal Results
27th Mar 20183:18 pmRNSCapital Reduction
22nd Feb 20187:00 amRNSSainsbury's sign 3-year agreement with Ingenta
19th Feb 201811:36 amRNSResult of General Meeting
26th Jan 20187:01 amRNSNotice of GM and Proposed Capital Reduction
26th Jan 20187:00 amRNSTrading Update
20th Nov 20177:00 amRNSYewno Appoints PCG to Drive Sales
21st Sep 20173:10 pmRNSGrant of Options
19th Sep 201710:16 amRNSDirector/PDMR Shareholding
18th Sep 201712:21 pmRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSInterim Results
15th Aug 20177:00 amRNSContract Win
15th Aug 20177:00 amRNSPre Close Trading Update
19th Jun 201711:41 amRNSDirectorate Disclosure
31st May 20173:50 pmRNSResult of AGM
18th May 20172:36 pmRNSPosting of Annual Report and Accounts
7th Apr 20179:28 amRNSDividend Declaration and notice of AGM
3rd Apr 20177:00 amRNSFinal Results
16th Jan 20177:00 amRNSTrading Update
30th Dec 20162:00 pmRNSDirector/PDMR Shareholding
30th Dec 20161:54 pmRNSDirector/PDMR Shareholding
6th Dec 20165:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.